168 related articles for article (PubMed ID: 37940817)
1. Human milk oligosaccharides 3'-sialyllactose and 6'-sialyllactose attenuate LPS-induced lung injury by inhibiting STAT1 and NF-κB signaling pathways.
Jin Y; Jeon H; Le Lam Nguyen T; Kim L; Heo KS
Arch Pharm Res; 2023 Dec; 46(11-12):897-906. PubMed ID: 37940817
[TBL] [Abstract][Full Text] [Related]
2. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
[TBL] [Abstract][Full Text] [Related]
3. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
4. 3'-Sialyllactose protects against LPS-induced endothelial dysfunction by inhibiting superoxide-mediated ERK1/2/STAT1 activation and HMGB1/RAGE axis.
Nguyen DV; Jin Y; Nguyen TLL; Kim L; Heo KS
Life Sci; 2024 Feb; 338():122410. PubMed ID: 38191050
[TBL] [Abstract][Full Text] [Related]
5. JFNE-A isolated from Jing-Fang n-butanol extract attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and the NF-κB signaling pathway via promotion of autophagy.
Rao Z; Zeng J; Li X; Peng L; Wang B; Luan F; Zeng N
Phytomedicine; 2022 Feb; 96():153891. PubMed ID: 35026506
[TBL] [Abstract][Full Text] [Related]
6. LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.
Li C; Yang D; Cao X; Wang F; Jiang H; Guo H; Du L; Guo Q; Yin X
Biochem Pharmacol; 2016 Aug; 113():57-69. PubMed ID: 27206337
[TBL] [Abstract][Full Text] [Related]
7. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI.
Cai J; Wang YL; Sheng XD; Zhang L; Lv X
J Ethnopharmacol; 2022 Nov; 298():115661. PubMed ID: 36002086
[TBL] [Abstract][Full Text] [Related]
8. Minor Ginsenoside Rg2 and Rh1 Attenuates LPS-Induced Acute Liver and Kidney Damages via Downregulating Activation of TLR4-STAT1 and Inflammatory Cytokine Production in Macrophages.
Huynh DTN; Baek N; Sim S; Myung CS; Heo KS
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932915
[TBL] [Abstract][Full Text] [Related]
9. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
10. Cardamine komarovii flower extract reduces lipopolysaccharide-induced acute lung injury by inhibiting MyD88/TRIF signaling pathways.
Chen Q; Zhang KX; Li TY; Piao XM; Lian ML; An RB; Jiang J
Chin J Nat Med; 2019 Jun; 17(6):461-468. PubMed ID: 31262458
[TBL] [Abstract][Full Text] [Related]
11. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
12. ACT001 suppressing M1 polarization against inflammation via NF-κB and STAT1 signaling pathways alleviates acute lung injury in mice.
Guo H; Song Y; Li F; Fan Y; Li Y; Zhang C; Hou H; Shi M; Zhao Z; Chen Z
Int Immunopharmacol; 2022 Sep; 110():108944. PubMed ID: 35728304
[TBL] [Abstract][Full Text] [Related]
13. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
14. Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway.
Jin J; Xu W; Wan B; Wang X; Zhou Z; Miao Y; Lv T; Song Y
J Surg Res; 2019 Mar; 235():83-92. PubMed ID: 30691855
[TBL] [Abstract][Full Text] [Related]
15. Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response.
Wang X; Yan J; Xu X; Duan C; Xie Z; Su Z; Ma H; Ma H; Wei X; Du X
Microb Pathog; 2018 May; 118():170-176. PubMed ID: 29571724
[TBL] [Abstract][Full Text] [Related]
16. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
17. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G
Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291
[TBL] [Abstract][Full Text] [Related]
18. Semaglutide ameliorates lipopolysaccharide-induced acute lung injury through inhibiting HDAC5-mediated activation of NF-κB signaling pathway.
Jiang Z; Tan J; Yuan Y; Shen J; Chen Y
Hum Exp Toxicol; 2022; 41():9603271221125931. PubMed ID: 36075570
[TBL] [Abstract][Full Text] [Related]
19. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
Mo M; Li S; Dong Z; Li C; Sun Y; Li A; Zhao Z
Int Immunopharmacol; 2020 Apr; 81():106273. PubMed ID: 32070920
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]